Product Description
Griseofulvins an antifungal medication that fights infections caused by fungus. Griseofulvins used to treat infections such as ringworm, athletes foot, jock itch, and fungal infections of the scalp, fingernails, or toenails.
Specification
|
Packaging Size
|
25kg
|
|
Brand
|
NR
|
|
Manufacturer
|
NR
|
|
Composition
|
Griseofulvin
|
|
Treatment
|
Griseofulvin is an antifungal medication that fights infections caused by fungus. Griseofulvin is us
|
|
Prescription/Non prescription
|
Prescription
|
Pharmaceutical Grade QualityGriseofulvin IP Powder meets stringent IP monograph requirements, ensuring reliability and safety in antifungal applications. Each batch undergoes thorough testing for identity (via TLC/IR methods), assay (HPLC), heavy metals, loss on drying, and impurity profiles, so it is suitable for use in regulated pharmaceutical manufacturing environments.
Superior Compatibility and Formulation BenefitsThe powder is micronized to ensure particle uniformity, allowing seamless blending with commonly used excipients in tablets and capsules. Its physical stability and compatibility help in producing robust dosage forms with consistent therapeutic performance, meeting modern pharmaceutical formulation standards.
FAQs of Griseofulvin IP Powder:
Q: How is Griseofulvin IP Powder identified and tested for quality?
A: Each batch of Griseofulvin IP Powder is identified using TLC and IR techniques, and it complies with IP monograph standards, ensuring the correct chemical structure and purity. Assay is determined by HPLC (98.0101.0%), and stringent tests for impurities, residual solvents, and microbial limits are performed.
Q: What are the recommended storage conditions for Griseofulvin IP Powder?
A: Griseofulvin IP Powder should be stored in a cool, dry, and dark place, preferably in its original HDPE drum packaging or as specified by the client. Proper storage safeguards its stability, which is rated for 36 months under these conditions.
Q: When should Griseofulvin IP Powder be used in pharmaceutical formulations?
A: Use Griseofulvin IP Powder during the manufacturing of oral tablet or capsule formulations designed to treat systemic fungal infections, following prescribed pharmaceutical protocols for dosage forms. It is compatible with excipients widely used in pharmaceutical processes.
Q: Where is Griseofulvin IP Powder manufactured and distributed?
A: Griseofulvin IP Powder is available from reputable Indian manufacturers, distributors, exporters, importers, and service providers. Global pharmaceutical companies can source it for further formulation and distribution in various markets.
Q: What process ensures the powders compliance with regulatory standards?
A: Quality assurance involves comprehensive in-house and third-party testing for identity, purity (HPLC assay), organic impurities, microbial content, and compliance with EINECS and ICH Q3C (R6) guidelines for residual solvents. Documentation and traceability support regulatory submissions.
Q: How is Griseofulvin IP Powder used for medical benefit?
A: The powder serves as an active antifungal ingredient, especially effective for systemic treatments against dermatophyte infections when formulated as tablets or capsules. Its high purity and tailored particle size maximize therapeutic efficacy.
Q: What are the benefits of using Griseofulvin IP Powder in pharmaceutical development?
A: Its high purity, ease of formulation, physical stability, and regulatory compliance simplify development and production of effective antifungal medications. Additionally, non-hazardous characteristics and a 36-month shelf life add to its advantages for manufacturers.